BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24759139)

  • 21. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
    Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of red blood cells adjacent to and within a thrombus in experimental cerebral ischaemia.
    van der Spuy WJ; Pretorius E
    Thromb Res; 2013; 132(6):718-23. PubMed ID: 24188798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-vessel wall interaction in health and disease.
    Löwenberg EC; Meijers JC; Levi M
    Neth J Med; 2010 Jun; 68(6):242-51. PubMed ID: 20558854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil serine proteases: mediators of innate immune responses.
    Meyer-Hoffert U; Wiedow O
    Curr Opin Hematol; 2011 Jan; 18(1):19-24. PubMed ID: 21042214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.
    Abu-Fanne R; Stepanova V; Litvinov RI; Abdeen S; Bdeir K; Higazi M; Maraga E; Nagaswami C; Mukhitov AR; Weisel JW; Cines DB; Higazi AA
    Blood; 2019 Jan; 133(5):481-493. PubMed ID: 30442678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelets in atherosclerosis and thrombosis.
    Schulz C; Massberg S
    Handb Exp Pharmacol; 2012; (210):111-33. PubMed ID: 22918729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of immunothrombosis in paediatric conditions.
    Franchi T; Eaton S; De Coppi P; Giuliani S
    Pediatr Res; 2019 Jul; 86(1):19-27. PubMed ID: 30808021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threshold of microvascular occlusion: injury size defines the thrombosis scenario.
    Belyaev AV; Panteleev MA; Ataullakhanov FI
    Biophys J; 2015 Jul; 109(2):450-6. PubMed ID: 26200881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen-induced thrombosis in murine arteries and veins.
    Cooley BC
    Thromb Res; 2013 Jan; 131(1):49-54. PubMed ID: 23063056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis.
    Kimball AS; Obi AT; Diaz JA; Henke PK
    Front Immunol; 2016; 7():236. PubMed ID: 27446071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disseminated intravascular coagulation syndrome: morphological criteria].
    Zerbino DD; Lukasevich LL
    Arkh Patol; 1982; 44(7):29-35. PubMed ID: 7125936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.